Identification of a PCSK9-LDLR disruptor peptide with in vivo function

<i>Coot</i>: model-building tools for molecular graphics

Paul Emsley, Kevin Cowtan · Acta Crystallographica Section D Biological Crystallography · 2004 · 31K citations · Full text

<i>XDS</i>

Wolfgang Kabsch · Acta Crystallographica Section D Biological Crystallography · 2010 · 16.5K citations · Full text

Geometric Modeling, Program Package Xds, Image Analysis +14

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in <i>Phenix</i>

Dorothée Liebschner, Pavel V. Afonine, Matthew L. Baker et al. · Acta Crystallographica Section D Structural Biology · 2019 · 7K citations · Full text

X-ray Crystallography, X-ray Spectroscopy, Comprehensive Software Package +20

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.3K citations · Full text

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès et al. · Nature Genetics · 2003 · 3K citations

Genetic Disorder, Genetics, Pathology +4